VCM
PRCT icon

Voleon Capital Management’s Procept Biorobotics PRCT Stock Holding History

Voleon Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.63M Buy
65,159
+24,301
+59% +$685K 0.04% 362
2025
Q4 		$1.29M Buy
40,858
+34,246
+518% +$1.14M 0.03% 397
2025
Q3 		$236K Buy
+6,612
New +$302K 0.01% 786

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Voleon Capital Management's PRCT Position: Q1 2026 in Review

Voleon Capital Management increased its Procept Biorobotics (PRCT) stake by 59% in Q1 2026, buying an estimated $685K and bringing the position to 65,159 shares worth $1.63M. The position accounts for 0.04% of the portfolio, ranked #362.

Voleon Capital Management first reported a position in PRCT in Q3 2025 and has held it in 3 quarters since. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Voleon Capital Management held 65,159 shares of Procept Biorobotics worth $1.63M as of Q1 2026.
  • Voleon Capital Management bought 24,301 Procept Biorobotics shares in Q1 2026, an estimated $685K.
  • Procept Biorobotics made up 0.04% of Voleon Capital Management's portfolio in Q1 2026, its #362 holding.
  • Voleon Capital Management first reported a position in Procept Biorobotics in Q3 2025 and has held it in 3 quarters since.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.